Canrenone: Difference between revisions

Canrenone
Clinical data
ATC code	C03DA03 (WHO) ;
Identifiers
	IUPAC name 10,13-dimethylspiro[2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthrene-17,5'-oxolane]-2',3-dione;
CAS Number	976-71-6;
PubChem CID	319260;
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C22H28O3
Molar mass	340.456 g/mol

Revision as of 23:25, 8 August 2012

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Canrenone is an aldosterone antagonist. The active form, and first metabolite of, Spironolactone.

Revision as of 16:29, 27 September 2011 (view source) Matt Pijoan (talk \| contribs) m (Protected "Canrenone": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))		Revision as of 23:25, 8 August 2012 (view source) WikiBot (talk \| contribs) m (Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +)) Newer edit →
Line 27:		Line 27:
	{{CMG}}		{{CMG}}

	~~{{Editor Join}}~~

v t e Antihypertensives (C02) and diuretics (C03)
Sympatholytic agents	Template:Navbox subgroup
Vasodilators	Diazoxide • hydrazinophthalazine (Hydralazine, Dihydralazine, Endralazine, Cadralazine) • Minoxidil • Nitroprusside • Phentolamine
Other antihypertensives	serotonin antagonist (Ketanserin) • endothelin receptor antagonist (Bosentan, Ambrisentan, Sitaxsentan) • MAOI (Pargyline) • THI (Metirosine)
Diuretics	Template:Navbox subgroup

Clinical data

ATC code	C03DA03 (WHO)
Identifiers
IUPAC name 10,13-dimethylspiro[2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthrene-17,5'-oxolane]-2',3-dione
CAS Number	976-71-6
PubChem CID	319260
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C₂₂H₂₈O₃
Molar mass	340.456 g/mol